HF
XGN icon

HRT Financial’s Exagen XGN Stock Holding History

HRT Financial’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,725
Closed -$423K – 4869
2025
Q4 		$423K Buy
+69,725
New +$635K ﹤0.01% 2196

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

HRT Financial's XGN Position: Q1 2026 in Review

HRT Financial sold out of Exagen (XGN) in Q1 2026, closing a stake of 69,725 shares — an estimated $423K sold.

HRT Financial first reported a position in XGN in Q4 2025 and held it in 1 quarter. The position peaked at $423K in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • HRT Financial reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 69,725 Exagen shares in Q1 2026, an estimated $423K.
  • HRT Financial first reported a position in Exagen in Q4 2025 and held it in 1 quarter.
  • HRT Financial's Exagen position peaked at $423K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.